Logo image of GBT.PA

GUERBET (GBT.PA) Stock Price, Quote, News and Overview

EPA:GBT - Euronext Paris - Matif - FR0000032526 - Common Stock - Currency: EUR

27  +0.7 (+2.66%)

GBT.PA Quote, Performance and Key Statistics

GUERBET

EPA:GBT (3/7/2025, 7:00:00 PM)

27

+0.7 (+2.66%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week High40.25
52 Week Low24.25
Market Cap341.28M
Shares12.64M
Float5.41M
Yearly Dividend0.5
Dividend Yield1.9%
PE10.23
Fwd PE8.2
Earnings (Next)03-26 2025-03-26/amc
IPO01-15 1986-01-15


GBT.PA short term performance overview.The bars show the price performance of GBT.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10 -15

GBT.PA long term performance overview.The bars show the price performance of GBT.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40

The current stock price of GBT.PA is 27 EUR. In the past month the price increased by 3.85%. In the past year, price decreased by -16.92%.

GUERBET / GBT Daily stock chart

GBT.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
EL.PA ESSILORLUXOTTICA 53.13 124.44B
ESL.DE ESSILORLUXOTTICA 53.09 124.35B
1EL.MI ESSILORLUXOTTICA 52.97 124.08B
CBHD.DE COLOPLAST-B 33.98 21.00B
GENT.OL GENTIAN DIAGNOSTICS ASA 16.31 721.66M
ALCJ.PA CROSSJECT N/A 91.07M
PTP.DE PENTIXAPHARM HOLDING AG N/A 89.03M
AFME.PA AFFLUENT MEDICAL SA N/A 55.09M
SVS.MI SVAS BIOSANA SPA 7.25 41.44M
IVN.MI IVISION TECH SPA N/A 16.85M

About GBT.PA

Company Profile

GBT logo image Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France and currently employs 2,920 full-time employees. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

Company Info

GUERBET

15 rue des Vanesses, Zone Paris Nord II

Villepinte ILE-DE-FRANCE FR

Employees: 2920

Company Website: https://www.guerbet.com/

Investor Relations: http://www.guerbet.com/en/investors.html

Phone: 33145915000

GUERBET / GBT.PA FAQ

What is the stock price of GUERBET today?

The current stock price of GBT.PA is 27 EUR. The price increased by 2.66% in the last trading session.


What is the ticker symbol for GUERBET stock?

The exchange symbol of GUERBET is GBT and it is listed on the Euronext Paris - Matif exchange.


On which exchange is GBT.PA stock listed?

GBT.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for GUERBET stock?

8 analysts have analysed GBT.PA and the average price target is 42.59 EUR. This implies a price increase of 57.72% is expected in the next year compared to the current price of 27. Check the GUERBET stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GUERBET worth?

GUERBET (GBT.PA) has a market capitalization of 341.28M EUR. This makes GBT.PA a Small Cap stock.


How many employees does GUERBET have?

GUERBET (GBT.PA) currently has 2920 employees.


What are the support and resistance levels for GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a support level at 26.9 and a resistance level at 27.03. Check the full technical report for a detailed analysis of GBT.PA support and resistance levels.


Is GUERBET (GBT.PA) expected to grow?

The Revenue of GUERBET (GBT.PA) is expected to grow by 6.69% in the next year. Check the estimates tab for more information on the GBT.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy GUERBET (GBT.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GUERBET (GBT.PA) stock pay dividends?

GUERBET (GBT.PA) has a dividend yield of 1.9%. The yearly dividend amount is currently 0.5. Check the full fundamental report for a detailed analysis of GBT.PA dividend history, reliability and sustainability.


When does GUERBET (GBT.PA) report earnings?

GUERBET (GBT.PA) will report earnings on 2025-03-26, after the market close.


What is the Price/Earnings (PE) ratio of GUERBET (GBT.PA)?

The PE ratio for GUERBET (GBT.PA) is 10.23. This is based on the reported non-GAAP earnings per share of 2.64 and the current share price of 27 EUR. Check the full fundamental report for a full analysis of the valuation metrics for GBT.PA.


GBT.PA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to GBT.PA. When comparing the yearly performance of all stocks, GBT.PA is a bad performer in the overall market: 80.99% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

GBT.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to GBT.PA. GBT.PA has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GBT.PA Financial Highlights

Over the last trailing twelve months GBT.PA reported a non-GAAP Earnings per Share(EPS) of 2.64. The EPS increased by 177.5% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.97%
ROA 3.14%
ROE 8.43%
Debt/Equity 0.97
Chartmill High Growth Momentum
EPS Q2Q%443.75%
Sales Q2Q%10.71%
EPS 1Y (TTM)177.5%
Revenue 1Y (TTM)8.6%

GBT.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 85% to GBT.PA. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 119.14% and a revenue growth 6.69% for GBT.PA


Ownership
Inst Owners18.97%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts85
Price Target42.59 (57.74%)
EPS Next Y119.14%
Revenue Next Year6.69%